HLA-C and neoplasm: Moreover, in “cold” tumors, which are characterized by poor immunogenicity, YAP/TAZ-TEAD inhibition may increase the expression of major histocompatibility complex (MHC) molecules, essential for presenting tumor antigens to adaptive immune cells and initiating an antigen-specific anti-tumor immune response92.